Doctors test custom drug mixes based on tumor DNA
NCT ID NCT02624973
Summary
This study aims to find better drug combinations for high-risk breast cancer by matching treatments to each patient's unique tumor genetics. Doctors will analyze tumor DNA before treatment and assign one of several personalized drug regimens. The goal is to see if this approach shrinks tumors more effectively before surgery compared to standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Akershus University Hospital
Lørenskog, Akershus, Norway
-
Haukeland University Hospital
Bergen, Hordaland, 5021, Norway
-
Helse Fonna
Haugesund, Rogaland, Norway
-
Helse Førde
Førde, Sogn Og Fjordande, Norway
-
Helse Nord/UNN
Tromsø, Troms, Norway
-
Helse Stavanger
Stavanger, Rogaland, Norway
-
St. Olavs Hospital
Trondheim, Sør Trøndelag, Norway
Conditions
Explore the condition pages connected to this study.